Trial intelligence / Profile preview

Esketamine vs dezocine for postoperative intravenous analgesia after cesarean section in primiparous women

ChiCTR2100047419Phase 4Recruiting

Sponsor
Hunan University of Medicine General Hospital
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in postoperative pain and postpartum depression (PPD) (2 arms), sponsored by Hunan University of Medicine General Hospital. Primary endpoints: Vital signs, Analgesia score and 3 more. Started Apr 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

postoperative painpostpartum depression (PPD)

Beyond the preview

Go deeper on ChiCTR2100047419.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047419.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call